Alnylam Pharmaceuticals | 販売および管理費





販売および管理費 変化する 日付
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amgen USD 1.94B 237M 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
BioCryst Pharmaceuticals USD 80.47M 15.39M 2024-12
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Incyte USD 390.41M 61.33M 2025-12
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Moderna USD 308M 40M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.3B 137M 2025-09
PTC Therapeutics USD 87.2M 3.15M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Takeda JPY 282.78B 29.23B 2025-12
Tectonic Therapeutic USD 4.96M 190K 2025-09
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Xencor USD 87.78M 72.66M 2025-09


Alnylam Pharmaceuticals 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.